Staff Reporter (Health Care, Law)
Stephanie Henkel covers health care, biotech, law, insurance, advertising, marketing and public relations throughout the greater San Fernando Valley. She joined the company in September 2015.
Henkel previously interned as a foreign correspondent covering Turkey’s 2014 presidential election from Istanbul. Before that, she wrote content for Global Animal in Santa Monica, an animal-advocacy online magazine.
She has a Master of Arts degree in Mass Communication as well as a Bachelor of Science degree in Business Management, both from California State University Northridge.
Henkel can be reached at (818) 316-3130, or by email: firstname.lastname@example.org.
Phone: 818-316-3130 Extension: 124
Avery Dennison Corp. on Monday announced it has acquired health care product manufacturer Finesse Medical Ltd. of Longford, Ireland.
B. Riley Financial Inc. announced Thursday that it will acquire Memphis, Tenn.-based Wunderlich Securities in a deal valued at $67 million.
The 2017 Amgen Tour of California is rolling through Santa Clarita Wednesday as the city is the finish line for the fourth day of the men’s weeklong bicycle race.
MEDICINE: High pollen levels push demand for balloon sinuplasty procedure.
Allergists and doctors concur that this year is one of the worst allergy seasons in Valley history.
MEDICAL DEVICE: Lift prevents pain for patients, caregivers.
By making immobile patients easier to move, the makers of Boemba hope to relieve bedsores.
LIST: Projects range from a rehab clinic to building with half-billion dollar budget.
In growth mode, Valley hospitals expand facilities.
Student entrepreneurs compete for services and seed money.
CSUN’s pitch contest for startups features seed-money prizes.
Avita Medical Ltd., a Valencia company that makes regenerative treatments for wounds and skin defects, has filed a petition against a patent owned by competitor New York-based Renovacare Sciences Corp.
The U.S. Securities and Exchange Commission has accused 27 individuals and businesses of stock fraud, according to the Tampa Bay Business Journal, including former ImmunoCellular Therapeutics Ltd. chief executive Manish Singh.